Kristian Humer

Kristian Humer

Chief Financial Officerat4D Molecular Therapeutics· In the 2025 proxy

Pay in FY20254D Molecular Therapeutics stock +34.6% the same year

Kristian Humer was paid $4.0M in FY2025 (Dec). 4D Molecular Therapeutics stock rose 34.6% that year.

Pay$100 in the stock at the end of FY24 → $135
Pay is from the Summary Compensation Table of each 4D Molecular Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. 4D Molecular TherapeuticsPublic company · 1 yr
    • Chief Financial Officer2025 – Present · 1 yrStock in role +123%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?